ASND
Price
$175.57
Change
+$12.73 (+7.82%)
Updated
Jun 2, 04:59 PM (EDT)
Capitalization
10.63B
98 days until earnings call
NUVL
Price
$77.23
Change
+$2.62 (+3.51%)
Updated
Jun 2, 04:59 PM (EDT)
Capitalization
5.54B
66 days until earnings call
Interact to see
Advertisement

ASND vs NUVL

Header iconASND vs NUVL Comparison
Open Charts ASND vs NUVLBanner chart's image
Ascendis Pharma A/S
Price$175.57
Change+$12.73 (+7.82%)
Volume$4.47K
Capitalization10.63B
Nuvalent
Price$77.23
Change+$2.62 (+3.51%)
Volume$2.61K
Capitalization5.54B
ASND vs NUVL Comparison Chart
Loading...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASND vs. NUVL commentary
Jun 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a Hold and NUVL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 03, 2025
Stock price -- (ASND: $175.69 vs. NUVL: $77.18)
Brand notoriety: ASND and NUVL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 176% vs. NUVL: 103%
Market capitalization -- ASND: $10.63B vs. NUVL: $5.54B
ASND [@Biotechnology] is valued at $10.63B. NUVL’s [@Biotechnology] market capitalization is $5.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $307.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 0 FA rating(s) are green whileNUVL’s FA Score has 0 green FA rating(s).

  • ASND’s FA Score: 0 green, 5 red.
  • NUVL’s FA Score: 0 green, 5 red.
According to our system of comparison, ASND is a better buy in the long-term than NUVL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 7 TA indicator(s) are bullish while NUVL’s TA Score has 6 bullish TA indicator(s).

  • ASND’s TA Score: 7 bullish, 3 bearish.
  • NUVL’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, both ASND and NUVL are a good buy in the short-term.

Price Growth

ASND (@Biotechnology) experienced а +8.45% price change this week, while NUVL (@Biotechnology) price change was +5.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.09%. For the same industry, the average monthly price growth was +1.10%, and the average quarterly price growth was -0.30%.

Reported Earning Dates

ASND is expected to report earnings on Sep 09, 2025.

NUVL is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ASND($10.6B) has a higher market cap than NUVL($5.54B). ASND YTD gains are higher at: 27.617 vs. NUVL (-4.688). ASND has higher annual earnings (EBITDA): -305.15M vs. NUVL (-322.59M). NUVL has more cash in the bank: 1.07B vs. ASND (518M). ASND has higher revenues than NUVL: ASND (369M) vs NUVL (0).
ASNDNUVLASND / NUVL
Capitalization10.6B5.54B191%
EBITDA-305.15M-322.59M95%
Gain YTD27.617-4.688-589%
P/E RatioN/AN/A-
Revenue369M0-
Total Cash518M1.07B48%
Total Debt847MN/A-
FUNDAMENTALS RATINGS
ASND: Fundamental Ratings
ASND
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
77
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ASNDNUVL
RSI
ODDS (%)
Bearish Trend 4 days ago
71%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
79%
Momentum
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
85%
MACD
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
83%
Advances
ODDS (%)
Bullish Trend 5 days ago
71%
N/A
Declines
ODDS (%)
Bearish Trend 25 days ago
77%
Bearish Trend 6 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FCG22.480.46
+2.09%
First Trust Natural Gas ETF
LDEM51.190.47
+0.93%
iShares® ESG MSCI EM Leaders ETF
FBT161.880.60
+0.37%
First Trust NYSE Arca Biotech ETF
SSPY79.760.03
+0.04%
Stratified LargeCap Index ETF
AVUV87.98-0.15
-0.17%
Avantis US Small Cap Value ETF

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with CGON. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
-0.20%
CGON - NUVL
53%
Loosely correlated
-2.33%
ABCZF - NUVL
51%
Loosely correlated
N/A
KYMR - NUVL
51%
Loosely correlated
-2.02%
RVMD - NUVL
48%
Loosely correlated
+0.81%
CRNX - NUVL
48%
Loosely correlated
-0.03%
More